Methodology
Phase II
Second phase: preliminary efficacy and dose-finding.
Phase II trials assess preliminary efficacy and dose in patients with the target condition (100-300 subjects). Typically randomized and controlled. Duration: months to years.
Methodology
Second phase: preliminary efficacy and dose-finding.
Phase II trials assess preliminary efficacy and dose in patients with the target condition (100-300 subjects). Typically randomized and controlled. Duration: months to years.